Literature DB >> 32430574

Revisiting allostery in CREB-binding protein (CBP) using residue-based interaction energy.

Metin Yazar1,2, Pemra Ozbek3.   

Abstract

CREB-binding protein (CBP) is a multi-subunit scaffold protein complex in transcription regulation process, binding and interacting with ligands such as mixed-lineage leukemia (MLL) and c-Myb allosterically. Here in this study, we have revisited the concept of allostery in CBP via residue-based interaction energy calculation based on molecular dynamics (MD) simulations. To this end, we conducted MD simulations of KIX:MLL:c-Myb ternary complex, its binary components and kinase-inducible domain (KID) interacting domain (KIX) backbone. Interaction energy profiles and cross correlation analysis were performed and the results indicated that KIX:MLL and KIX:c-Myb:MLL complexes demonstrate significant similarities according to both analysis methods. Two regions in the KIX backbone were apparent from the interaction energy and cross correlation maps that hold a key to allostery phenomena observed in CBP. While one of these regions are related to the ligand binding residues, the other comprises of L12-G2 loop and α3 helix regions that have been found to have a significant role in allosteric signal propagation. All in all, residue-based interaction energy calculation method is demonstrated to be a valuable calculation technique for the detection of allosteric signal propagation and ligand interaction regions.

Entities:  

Keywords:  Allostery; CREB binding protein (CBP); Molecular dynamics simulations; Motional correlation analysis; Residue-based interaction energy

Year:  2020        PMID: 32430574     DOI: 10.1007/s10822-020-00316-y

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  1 in total

1.  Multivalent and Bidirectional Binding of Transcriptional Transactivation Domains to the MED25 Coactivator.

Authors:  Heather M Jeffery; Robert O J Weinzierl
Journal:  Biomolecules       Date:  2020-08-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.